Boots WebMD Partners in Health
Return To Boots

Smoking cessation health centre

Smoking references

BMJ Group Medical Reference

References

  1. Balfour DJ. The neurobiology of tobacco dependence: a commentary. Respiration. 2002; 69: 7-11.
  2. National Institute on Drug Abuse. NIDA infofacts: cigarettes and other nicotine products. August 2010. National Institute on Drug Abuse. Available at http://www.drugabuse.gov/Infofacts/tobacco.html (accessed on 24 April 2012).
  3. Simantov E, Schoen C, Klein JD. Health-compromising behaviors: why do adolescents smoke or drink? Identifying underlying risk and protective factors. Archives of Pediatrics and Adolescent Medicine. 2000; 154: 1025-1033.
  4. Rugkasa J, Knox B, Sittlington J, et al. Anxious adults vs. cool children: children's views on smoking and addiction. Social Science & Medicine. 2001; 53: 593-602.
  5. Cancer Research UK. Tobacco and cancer risk. December 2011. Available at http://info.cancerresearchuk.org/cancerstats/causes/lifestyle/tobacco/index.htm (accessed on 24 April 2012).
  6. European Commission. Directive 2001/37/EC of the European Parliament and of the Council of 5 June 2001 on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco products - commission statement. Available at March 2011. http://europa.eu/legislation_summaries/public_health/health_determinants_lifestyle/c11567_en.htm (accessed on 24 April 2012).
  7. Action on Smoking and Health UK (ASH). Factsheet no. 12: what's in a cigarette. July 2009. Available at http://www.ash.org.uk/information/facts-and-stats/fact-sheets (accessed on 24 April 2012).
  8. Action on Smoking and Health UK (ASH). Factsheet no. 13: pipe and cigar smoking. July 2009. Available at http://www.ash.org.uk/information/facts-and-stats/fact-sheets (accessed on 24 April 2012).
  9. Stolerman IP, Jarvis MJ. The scientific case that nicotine is addictive. Psychopharmacology. 1995; 117: 2-10, discussion 14-20.
  10. DiFranza JR, Savageau JA, Rigotti NA, et al. Development of symptoms of tobacco dependence in youths: 30 month follow up data from the DANDY study. Tobacco Control. 2002; 11: 228-235.
  11. Kandel DB, Chen K. Extent of smoking and nicotine dependence in the United States: 1991-1993. Nicotine and Tobacco Research. 2000; 2: 263-274.
  12. Stapleton J. Cigarette smoking prevalence, cessation and relapse. Statistical Methods in Medical Research. 1998; 7: 187-203.
  13. The Lowdown. Smoking. Available at http://www.getthelowdown.co.uk/body/smoking.aspx (accessed on 24 April 2012).
  14. Action on Smoking and Health UK (ASH). Smoking statistics. July 2011. Available at http://www.ash.org.uk/information/facts-and-stats/fact-sheets (accessed on 24 April 2012).
  15. Cancer Research UK. Smoking - statistics. April 2012. Available at http://info.cancerresearchuk.org/cancerstats/types/lung/smoking (accessed on 24 April 2012).
  16. Office for National Statistics. General household survey 2006. Smoking and drinking among adults. January 2008. Available at http://www.parliament.uk/deposits/depositedpapers/2008/DEP2008-2395.pdf (accessed on 24 April 2012).
  17. Office for National Statistics. General household survey 2006. Smoking and drinking among adults. January 2008. Available at http://www.parliament.uk/deposits/depositedpapers/2008/DEP2008-2395.pdf (accessed on 24 April 2012).
  18. Department of Health. Smoking kills: a white paper on tobacco. November 1998. Available at http://www.archive.official-documents.co.uk/document/cm41/4177/4177.htm (accessed on 3 January 2012).
  19. Burns DM. Nicotine addiction. In: Braunwald E, Fauci AS, Kasper DL (editors). Harrison's Principles of Internal Medicine. 15th edition. McGraw-Hill, London, UK; 2001.
  20. Kenfield SA, Stampfer MJ, Rosner BA, et al. Smoking and smoking cessation in relation to mortality in women. Journal of the American Medical Association. 2008; 299: 2037-47.
  21. Action on Smoking and Health UK (ASH). Factsheet no. 8: passive smoking. July 2009. Available at http://www.ash.org.uk/information/facts-and-stats/fact-sheets (accessed on 24 April 2012).
  22. Dresler C, Leon M. Tobacco control reversal of risk after quitting smoking. IARC handbooks of cancer prevention. Volume 11. International Agency for Research on Cancer, Lyon, France; 2007.
  23. Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000; 321: 323-329.
  24. Doll R, Peto R, Boreham J, et al. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ. 2004; 328: 1519.
  25. Ussher M, West R, Steptoe A, et al. Increase in common cold symptoms and mouth ulcers following smoking cessation. Tobacco Control. 2003;12:86-8.
  26. Ockene JK, Emmons KM, Mermelstein RJ, et al. Relapse and maintenance issues for smoking cessation. Health Psychology. 2000; 19 (supplement 1): S17-S31.
  27. Richardson GE, Tucker MA, Venzon DJ, et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Annals of Internal Medicine. 1993; 119: 383-90.
  28. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. Journal of the American Medical Association. 1994; 272: 1497-1505.
  29. Buist AS, Sexton GJ, Nagy JM, et al. The effect of smoking cessation and modification on lung function. American Review of Respiratory Disease. 1976; 114: 115-122.
  30. Kanner RE, Connett JE, Williams DE, et al. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease. American Journal of Medicine. 1999; 106: 410-416.
  31. Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer: nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. Journal of Clinical Gastroenterology. 1997; 24: 2-17.
  32. Krall EA, Dawson-Hughes B. Smoking increases bone loss and decreases intestinal calcium absorption. Journal of Bone & Mineral Research. 1999; 14: 215-220.
  33. Cummings SR. Treatable and untreatable risk factors for hip fracture. Bone. 1996; 18 (supplement): S165-S167.
  34. Cornuz J, Feskanich D, Willett WC, et al. Smoking, smoking cessation, and risk of hip fracture in women. American Journal of Medicine. 1999; 106: 311-314.
  35. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ. 1997; 315: 841-846.
  36. NHS Choices: Smokefree. Why quit? Available at http://smokefree.nhs.uk/why-quit (accessed on 24 April 2012).
  37. Williamson DF, Madans J, Anda RF, et al. Smoking cessation and severity of weight gain in a national cohort. New England Journal of Medicine. 1991; 324: 739-745.
  38. Giovino GA, Henningfield JE, Tomar SL, et al. Epidemiology of tobacco use and dependence. Epidemiology Review. 1995; 17: 48-65.
  39. Agency for Health Care Policy and Research. The Agency for Health Care Policy and Research smoking cessation clinical practice guideline. Journal of the American Medical Association. 1996; 275: 1270-1280.
  40. National Institute for Health and Clinical Excellence. Brief interventions and referral for smoking cessation in primary care and other settings. March 2006. Public health guidance 1. Available at http://www.nice.org.uk/guidance/index.jsp?action=byID&r=true&o=11375 (accessed on 24 April 2012).
  41. National Institute for Health and Clinical Excellence. Smoking cessation services. February 2008. Public health guidance 10. Available at http://www.nice.org.uk/nicemedia/pdf/PH010quickrefguide1.pdf (accessed on 24 April 2012).
  42. Medicines and Healthcare products Regulatory Agency. New advice on use of nicotine replacement therapy (NRT): wider access in at-risk populations. December 2005. Available at http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON2022933 (accessed on 24 April 2012).
  43. Lancaster T, Stead LF. Physician advice for smoking cessation (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  44. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  45. Rice VH, Stead LF. Nursing interventions for smoking cessation (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  46. Lancaster T, Stead LF. Self-help interventions for smoking cessation (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  47. Stead LF, Lancaster T, Perera R. Telephone counselling for smoking cessation (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  48. Barth J, Critchley J, Bengel J. Psychosocial interventions for smoking cessation in patients with coronary heart disease (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  49. Lumley J, Oliver S, Waters E. Interventions for promoting smoking cessation during pregnancy (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  50. Rigotti NA, Munafo MR, Murphy MF, et al. Interventions for smoking cessation in hospitalised patients (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  51. Andrews JO, Felton G, Ellen Wewers M, et al. The effect of a multi-component smoking cessation intervention in African American women residing in public housing. Research in Nursing and Health. 2007; 30: 45-60.
  52. Aveyard P, Brown K, Saunders C. Weekly versus basic smoking cessation support in primary care: a randomised controlled trial. Thorax. 2007; 62: 898-903.
  53. Butler CC, Pill R, Stott NC. Qualitative study of patients' perceptions of doctors' advice to quit smoking: implications for opportunistic health promotion. BMJ. 1998; 316: 1878-1981.
  54. Solberg LI, Boyle RG, Davidson G, et al. Patient satisfaction and discussion of smoking cessation during clinical visits. Mayo Clinic Proceedings. 2001; 76: 138-143.
  55. Law M, Tang JL. An analysis of the effectiveness of interventions intended to help people stop smoking. Archives of Internal Medicine. 1995; 155: 1933-1941.
  56. Hajek P, West R, Lee A, et al. Randomized controlled trial of a midwife-delivered brief smoking cessation intervention in pregnancy. Addiction. 2001; 96: 485-494.
  57. Stotts AL, Diclemente CC, Dolan-Mullen P. One-to-one: a motivational intervention for resistant pregnant smokers. Addictive Behaviors. 2002; 27: 275-292.
  58. van der Meer RM, Wagena EJ, Ostelo RW, et al. Smoking cessation for chronic obstructive pulmonary disease (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  59. Humerfelt S, Eide GE, Kvale G, et al. Effectiveness of postal smoking cessation advice: a randomized controlled trial in young men with reduced FEV1 and asbestos exposure. European Respiratory Journal. 1998; 11: 284-290.
  60. Reid R, Pipe A, Higginson L, et al. Stepped care approach to smoking cessation in patients hospitalized for coronary artery disease. Journal of Cardiopulmonary Rehabilitation. 2003; 23: 176-182.
  61. Simon JA, Carmody TP, Hudes ES, et al. Intensive smoking cessation counseling versus minimal counseling among hospitalized smokers treated with transdermal nicotine replacement: a randomized trial. American Journal of Medicine. 2003; 114: 555-562.
  62. Schnoll RA, Zhang B, Rue M, et al. Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group. Journal of Clinical Oncology. 2003; 21: 355-365.
  63. Silagy C, Lancaster T, Stead L, et al. Nicotine replacement therapy for smoking cessation (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  64. U.S. Food and Drug Administration. FDA warns sellers of nicotine lollipops, lip balm. FDA Consumer. 2002; 36: 5-6.
  65. U.S. Food and Drug Administration. FDA and public health experts warn about electronic cigarettes. Available at http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm173222.htm (accessed on 24 April 2012).
  66. Medicines and Healthcare products Regulatory Agency. New advice on use of nicotine replacement therapy (NRT): wider access in at-risk populations. December 2005. Available at http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON2022933 (accessed on 24 April 2012).
  67. Rustin TA. Pharmacologic treatment of nicotine dependence. In: The certificate review course in addiction to nicotine for the American Society of Addiction Medicine. American Society of Addiction Medicine, Chevy Chase, U.S.A.; 1998.
  68. Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction. 1991; 86: 1119-1127.
  69. Mallin R. Smoking cessation: integration of behavioral and drug therapies. American Family Physician. 2002; 65: 1107-1114.
  70. British National Formulary. Drugs used in substance dependence. Section 4.10. British Medical Association and Royal Pharmaceutical Society of Great Britain. Also available at http://bnf.org (accessed on 24 April 2012).
  71. Lancaster T, Stead L, Silagy C, et al. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ. 2000; 321: 355-358.
  72. Medicines and Healthcare products Regulatory Agency. New advice on use of nicotine replacement therapy (NRT): wider access in at-risk populations. December 2005. Available at http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON2022933 (accessed on 24 April 2012).
  73. Morales-Suárez-Varela MM, Bille C, Christensen K, et al. Smoking habits, nicotine use, and congenital malformations. Obstetrics & Gynecology. 2006; 107: 51-57.
  74. Daughton DM, Fortmann SP, Glover ED, et al. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Preventive Medicine. 1999; 28: 113-118.
  75. Stapleton JA, Sutherland G, Russell MA. How much does relapse after one year erode effectiveness of smoking cessation treatments? Long-term follow up of randomised trial of nicotine nasal spray. BMJ. 1998; 316: 830-831.
  76. Yudkin P, Hey K, Roberts S, et al. Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patch. BMJ. 2003; 327: 28-29.
  77. Lerman C, Kaufmann V, Rukstalis M. Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial. Annals of Internal Medicine. 2004; 140: 426-433.
  78. Wu P, Wilson K, Dimoulas P. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health. 2006; 6: 300.
  79. Prochazka AV. New developments in smoking cessation. Chest. 2000; 117 (supplement): S169-S175.
  80. Fant RV, Owen LL, Henningfield JE. Nicotine replacement therapy. Primary Care; Clinics in Office Practice. 1999; 26: 633-652.
  81. Morales-Suárez-Varela MM, Bille C, Christensen K, et al. Smoking habits, nicotine use, and congenital malformations. Obstetrics & Gynecology. 2006; 107: 51-57.
  82. Silagy C, Lancaster T, Stead L, et al. Nicotine replacement therapy for smoking cessation (Cochrane review). In: The Cochrane Library. Update Software, Oxford, UK.
  83. Wisborg K, Henriksen TB, Jespersen LB, et al. Nicotine patches for pregnant smokers: a randomized controlled study. Obstetrics & Gynecology. 2000; 96: 967-971.
  84. Morales-Suárez-Varela MM, Bille C, Christensen K, et al. Smoking habits, nicotine use, and congenital malformations. Obstetrics & Gynecology. 2006; 107: 51-57.
  85. National Institute for Health and Clinical Excellence. Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation. December 2011. Available at http://www.nice.org.uk/TA039 (accessed on 24 April 2012).
  86. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  87. Tonstad S, Farsang C, Klaene G, et al. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. European Heart Journal. 2003; 24: 946-955.
  88. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  89. Pesola GR, Avasarala J. Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department. Journal of Emergency Medicine. 2002; 22: 235-239.
  90. U.S. Food and Drug Administration. Public health advisory: FDA requires new boxed warnings for the smoking cessation drugs Chantix and Zyban. July 2009. Available at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm169988.htm (accessed on 24 April 2012).
  91. Medicines and Healthcare products Regulatory Agency. Implementation of warnings on suicidal thoughts and behaviour in antidepressants. February 2008. Available at http://www.mhra.gov.uk/NewsCentre/CON2033960 (accessed on 24 April 2012).
  92. Wooltorton E. Bupropion (Zyban, Wellbutrin SR): reports of deaths, seizures, serum sickness. Canadian Medical Association Journal. 2002; 166: 68.
  93. Medicines and Healthcare products Regulatory Agency. 'Stop smoking' treatments. April 2011. Available at http://www.mhra.gov.uk/Safetyinformation/Generalsafetyinformationandadvice/Product-specificinformationandadvice/Product-specificinformationandadvice%E2%80%93M%E2%80%93T/Stopsmokingtreatments/index.htm (accessed on 24 April 2012).
  94. United States Pharmacopeia Dispensing Information (USPDI). Drug information for the health care professional. Micromedex. 2002; 1: 1518-23.
  95. British National Formulary. Drugs used in substance dependence. Section 4.10. British Medical Association and Royal Pharmaceutical Society of Great Britain. Also available at http://bnf.org (accessed on 24 April 2012).
  96. Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. Journal of the American Medical Association. 2006; 296: 56-63.
  97. Montvale NJ. Chantix. In: Physicians' Desk Reference 2007. Thomson, Toronto, Canada; 2006.
  98. Medicines and Healthcare products Regulatory Agency. Europe-wide review recommends updates to product information for varenicline (brand name Champix). December 2007. Available at http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON2033390 (accessed on 24 April 2012).
  99. Gunnell D, Irvine D, Wise L, et al. Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database. BMJ. 2009; 339: 3805.
  100. U.S. Food and Drug Administration. The Adverse Event Reporting System (AERS) latest quarterly data files. April 2012. Available at http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm082193.htm (accessed on 24 April 2012).
  101. Institute for Safe Medication Practices. Strong safety signal seen for new varenicline risks. Available at http://www.ismp.org/quarterwatch/chantixReport.asp (accessed on 24 April 2012).
  102. Ussher MH, West R, Taylor AH, et al. Exercise interventions for smoking cessation (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  103. Marcus BH, Albrecht AE, King TK, et al. The efficacy of exercise as an aid for smoking cessation in women: a randomized controlled trial. Archives of Internal Medicine. 1999; 159: 1229-1234.
  104. Taylor AH, Ussher MH, Faulkner G. The acute effects of exercise on cigarette cravings, withdrawal symptoms, affect and smoking behaviour: a systematic review. Addiction. 2007; 102: 534-543.
  105. Ebrahim S, Davey SG. Health promotion in older people for the prevention of coronary heart disease and stroke. Health Education Authority, London, UK; 1996.
  106. Carlsson C. Acupuncture mechanisms for clinically relevant long-term effects: reconsideration and a hypothesis. Acupuncture in Medicine. 2002; 20; 82-99.
  107. White AR, Rampes H, Campbell JL. Acupuncture and related interventions for smoking cessation (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  108. Wen HL, Cheung SYC. Treatment of drug addiction by acupuncture and electrical stimulation. Asian Journal of Medicine. 1973; 9: 138-141.
  109. White A, Hayhoe S, Hart A, et al. Adverse events following acupuncture: prospective survey of 32 000 consultations with doctors and physiotherapists. BMJ. 2001; 323: 485-486.
  110. MacPherson H, Thomas K, Walters S, et al. The York acupuncture safety study: prospective survey of 34 000 treatments by traditional acupuncturists. BMJ. 2001; 323: 486-487.
  111. Ernst E, White A. Acupuncture: safety first. BMJ. 1997; 314: 1362.
  112. White AR, Rampes H, Campbell JL. Acupunture and related interventions for smoking cessation (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  113. Hughes JR, Stead LF, Lancaster T. Anxiolytics for smoking cessation (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  114. Gourlay SG, Stead LF, Benowitz NL. Clonidine for smoking cessation (Cochrane Review). In: The Cochrane Library. Wiley, Chichester, UK.
  115. Vickers A, Zollman C. ABC of complementary medicine: hypnosis and relaxation therapies. BMJ. 1999; 319: 1346-1349.
  116. British National Formulary. Antidepressant drugs. Section 4.3. British Medical Association and Royal Pharmaceutical Society of Great Britain. Also available at http://bnf.org (accessed on 24 April 2012).
  117. U.S. Food and Drug Administration. Antidepressant use in children, adolescents, and adults. May 2007. Available at http://www.fda.gov (accessed on 3 April 2012).

Citations

Last Updated: June 21, 2012
This information does not replace medical advice.  If you are concerned you might have a medical problem please ask your Boots pharmacy team in your local Boots store, or see your doctor.

Popular slideshows & tools on BootsWebMD

woman looking at pregnancy test
Early pregnancy symptoms
donut on plate
The truth about sugar addiction
smiling african american woman
Best kept secrets for beautiful hair
couple watching sunset
How much do you know?
nappy being changed
How to change your baby's nappy
woman using moisturizer
Causes and home solutions
assorted spices
Pump up the flavour with spices
bag of crisps
Food cravings that wreck your diet
woman with cucumbers on eyes
How to banish dark circles and bags
probiotic shakes
Help digestion
polka dot dress on hangar
Lose weight without dieting